NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma

NCT01521533 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

TME Pharma AG